zinc oxide has been researched along with rifampin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dehghanpour, M; Fathizadeh, S; Jafari Nodooshan, S; Jafari, A; Kamalzadeh, M; Majidpour, A; Mosavari, N; Movahedzadeh, F; Novin Kashani, A; Rasouli Koohi, S; Safarkar, R | 1 |
Al-Ejji, M; Chiappi, M; Ellis, T; GarcĂa-Trenco, A; Georgiou, TK; Porter, AE; Ryan, MP; Sarkar, S; Schwander, S; Shaffer, MSP; Tetley, TD | 1 |
Esmaeili, A; Masoumi, S | 1 |
Bahkali, AH; Elgorban, AM; Harini, G; Khan, SS; Rahiman, MK; Syed, A; Varma, RS | 1 |
4 other study(ies) available for zinc oxide and rifampin
Article | Year |
---|---|
Toxicity effects of AgZnO nanoparticles and rifampicin on Mycobacterium tuberculosis into the macrophage.
Topics: Antitubercular Agents; Cell Line; Cell Survival; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanoparticles; Phagocytosis; Rifampin; Silver; Zinc Oxide | 2018 |
Multimetallic Microparticles Increase the Potency of Rifampicin against Intracellular Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cell Line; Cell Membrane; Cell Survival; Dose-Response Relationship, Drug; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanoparticles; Rifampin; Silver; Structure-Activity Relationship; Zinc Oxide | 2018 |
New method of creating hybrid of buprenorphine loaded rifampin/polyethylene glycol/alginate nanoparticles.
Topics: Alginates; Animals; Anti-Bacterial Agents; Buprenorphine; Drug Liberation; Ferric Compounds; Liver; Nanoparticles; Narcotic Antagonists; Polyethylene Glycols; Rats; Rats, Wistar; Rifampin; Zinc Oxide | 2020 |
Enhanced photodegradation of rifampicin and co-trimoxazole by ZnO/ZnMn
Topics: Onions; Oxygen; Photolysis; Rifampin; Sulfides; Trimethoprim, Sulfamethoxazole Drug Combination; Zinc Compounds; Zinc Oxide | 2022 |